Holen Sie sich die Stockscreener-App
2.6416
0.06%
0.0016
Schlusskurs vom Vortag:
$2.64
Offen:
$2.63
24-Stunden-Volumen:
334.32K
Relative Volume:
0.53
Marktkapitalisierung:
$186.73M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-1.7611
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
-4.29%
1M Leistung:
-6.66%
6M Leistung:
-36.50%
1J Leistung:
-68.33%
1-Tages-Spanne:
$2.575
$2.69
1-Wochen-Bereich:
$2.575
$2.89
52-Wochen-Spanne:
$2.015
$8.52
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Vergleichen Sie HCAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
2.64 | 186.73M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
232.04 | 39.30B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
76.28 | 13.71B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.62 | 8.60B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.25 | 7.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.34 | 6.23B | 11.99B | 24.18M | 234.31M | 0.2956 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Health Catalyst's Market Cap Drops To US$190m Leaving Insiders With Losses - simplywall.st
What technical patterns form on Health Catalyst Inc. (2YP) stock chartsWeekly Market Outlook & Precise Buy Zone Tips - Newser
How Health Catalyst Inc. (2YP) stock behaves in tightening cyclesLong Setup & Weekly Market Pulse Alerts - Newser
Is Health Catalyst Inc. (2YP) stock positioned for digital growth era2025 Market Overview & Fast Moving Stock Watchlists - Newser
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Is Health Catalyst Inc. (2YP) stock supported by free cash flowWeekly Investment Summary & Stock Timing and Entry Methods - Newser
Why Health Catalyst Inc stock is a must watch in 2025 - BỘ NỘI VỤ
Will Health Catalyst Inc. (2YP) stock sustain bullish trend into 20252025 Technical Overview & Weekly High Return Forecasts - Newser
Health Catalyst appoints largest shareholder’s CEO to board By Investing.com - Investing.com Canada
Is Health Catalyst Inc. (2YP) stock expanding market penetrationJuly 2025 Summary & Real-Time Volume Analysis Alerts - Newser
Can Health Catalyst Inc. (2YP) stock sustain breakout momentumJuly 2025 Earnings & Daily Stock Trend Reports - Newser
Matt Arens, CEO and founder of Health Catalyst's largest shareholder, First Light Asset Management, joins board of directors - marketscreener.com
Matt Arens, CEO And Founder Of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board Of Directors - TradingView
Health Catalyst appoints largest shareholder’s CEO to board - Investing.com
Health Catalyst Appoints New Board Member Matt Arens - TipRanks
Health Catalyst Appoints Matt Arens to Board of Directors - TradingView
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors - marketscreener.com
Will Health Catalyst Inc. (2YP) stock justify high valuationWeekly Profit Recap & AI Driven Price Forecasts - Newser
Will Health Catalyst Inc. (2YP) stock gain from lower interest ratesTrade Signal Summary & Entry Point Strategy Guides - Newser
Why Health Catalyst Inc. stock is a must watch in 2025July 2025 Short Interest & AI Forecasted Entry/Exit Points - moha.gov.vn
Can Health Catalyst Inc. stock deliver strong Q4 earnings2025 Dividend Review & Fast Gain Stock Trading Tips - BỘ NỘI VỤ
Health Catalyst and Unity Stocks Trade Up, What You Need To Know - The Globe and Mail
Health Catalyst and ON24 Stocks Trade Up, What You Need To Know - The Globe and Mail
Can Health Catalyst Inc. (2YP) stock hold up in economic slowdownQuarterly Earnings Summary & Fast Exit and Entry Strategy Plans - newser.com
Unity, Wix, Upstart, Samsara, and Health Catalyst Shares Are Falling, What You Need To Know - The Globe and Mail
Why Health Catalyst Inc. stock could outperform in 2025Breakout Watch & Capital Efficient Trade Techniques - newser.com
Health Catalyst Inc. stock trend outlook and recovery pathQuarterly Earnings Summary & Intraday High Probability Setup Alerts - newser.com
Identifying reversal signals in Health Catalyst Inc.July 2025 Drop Watch & Community Shared Stock Ideas - newser.com
Is Health Catalyst Inc. (2YP) stock good for wealth creation2025 Stock Rankings & Daily Market Momentum Tracking - newser.com
Will Health Catalyst Inc. stock benefit from green energy trends2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q3 Earnings? - Barchart.com
Building trade automation scripts for Health Catalyst Inc.Trade Ideas & Safe Capital Preservation Plans - newser.com
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.77%
3.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):